CASSAVA SCIENCES INC's ticker is SAVA and the CUSIP is 14817C107. A total of 190 filers reported holding CASSAVA SCIENCES INC in Q3 2021. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $215,000 | -49.1% | 5,132 | -54.9% | 0.00% | 0.0% |
| Q1 2022 | $422,000 | -16.9% | 11,372 | -2.3% | 0.00% | 0.0% |
| Q4 2021 | $508,000 | -29.8% | 11,634 | -0.2% | 0.00% | 0.0% |
| Q3 2021 | $724,000 | -51.1% | 11,660 | -32.7% | 0.00% | -66.7% |
| Q2 2021 | $1,480,000 | +92.2% | 17,322 | +1.2% | 0.00% | +200.0% |
| Q1 2021 | $770,000 | +305.3% | 17,122 | -38.6% | 0.00% | – |
| Q4 2020 | $190,000 | -72.7% | 27,897 | -53.8% | 0.00% | -100.0% |
| Q3 2020 | $695,000 | – | 60,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,739,540 | $7,150,000 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 615,000 | $2,528,000 | 0.32% |
| Worth Venture Partners, LLC | 48,535 | $200,000 | 0.12% |
| Ikarian Capital, LLC | 300,000 | $1,233,000 | 0.09% |
| Orbimed Advisors | 250,000 | $1,530,000 | 0.03% |
| Quinn Opportunity Partners LLC | 35,687 | $147,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 38,356 | $158,000 | 0.01% |
| Jefferies Group LLC | 80,000 | $329,000 | 0.00% |
| ClariVest Asset Management LLC | 33,403 | $137,000 | 0.00% |
| Renaissance Technologies | 653,759 | $2,687,000 | 0.00% |